ENTITY
Avid Bioservices

Avid Bioservices (CDMO US)

8
Analysis
Health CareUnited States
Avid Bioservices, Inc. operates as a pharmaceutical company. The Company focuses on development and manufacturing of biopharmaceutical products derived from mammalian cell culture, as well as provides clinical and commercial manufacturing services. Avid Bioservices serves customers in the United States.
more
Refresh
07 Dec 2020 10:50

Avid Bioservices: Strong Quarterly Performance Led to 25%+ Re-Rating Last Week. More to Go.

Avid is doing all the right things since it became a pure-play CDMO in CY2017. Over last 3 months, the stock has been up 65%+ led by strong...

Logo
195 Views
Share
05 Sep 2020 20:25
Logo
265 Views
Share
20 Aug 2020 08:59

US Hidden Gems | Avid Bioservices: Transitioning Avidly to Pure-Play Biologics CDMO

Avid Bioservices Inc (CDMO US) (“Avid”) is a $480mm market-cap US based pure-play biologics CDMO (Contract Development & Manufacturing...

Logo
344 Views
Share
x